Recent advances in imaging in management of symptomatic internal carotid artery disease

International Journal of Stroke

Volumn 2, Issue 2, 2007, Pages 97-103

  Szabo, Kristina ^a   Kern, Rolf ^a   Hennerici, Michael G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CONTRAST MEDIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATHEROSCLEROTIC PLAQUE; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW; SPIN LABELING; STENT;

CAROTID ARTERY DISEASES; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC IMAGING; HUMANS;

EID: 34247864014     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2007.00103.x     Document Type: Review

References (52)

1. Fisher M: Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951; 65: 346-77.
2. Chambers BR, Norris JW: Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986; 315: 860-5.
3. Hennerici M, Hulsbomer HB, Hefter H, Lammerts D, Rautenberg W: Natural history of asymptomatic extracranial arterial disease. Results of a long-term prospective study. Brain 1987; 110: 777-91.
4. North American symptomatic carotid endarterectomy trial collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-53.
5. The CASANOVA study group: Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991; 22: 1229-35.
6. Executive committee for the asymptomatic carotid atherosclerosis study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-8.
7. Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1998; 339: 1415-25.
8. Rothwell PM, Warlow CP: Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study. European carotid surgery trialists' collaborative group. Lancet 1999; 353: 2105-10.
9. Sacco RL: Clinical practice. Extracranial carotid stenosis. N Engl J Med 2001; 345: 1113-8.
10. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
11. Le Bihan D: Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991; 7: 1-30.
12. Hennerici M, Daffertshofer M, Jakobs L: Failure to identify cerebral infarct mechanisms from topography of vascular territory lesions. Am J Neuroradiol 1998; 19: 1067-74.
13. Caplan LR, Hennerici M: Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475-82.
14. Szabo K, Kern R, Gass A, Hirsch J, Hennerici M: Acute stroke patterns in patients with internal carotid artery disease: A diffusion-weighted magnetic resonance imaging study. Stroke 2001; 32: 1323-9.
15. Roh JK, Kang DW, Lee SH, Yoon BW, Chang KH: Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke 2000; 31: 688-94.
16. Baird AE, Lovblad KO, Schlaug G, Edelman RR, Warach S: Multiple acute stroke syndrome: Marker of embolic disease? Neurology 2000; 54: 674-8.
17. Kastrup A, Schulz JB, Mader I, Dichgans J, Kuker W: Diffusion-weighted MRI in patients with symptomatic internal carotid artery disease. J Neurol 2002; 249: 1168-74.
18. Kang DW, Chu K, Ko SB, Kwon SJ, Yoon BW, Roh JK: Lesion patterns and mechanism of ischemia in internal carotid artery disease: A diffusion-weighted imaging study. Arch Neurol 2002; 59: 1577-82.
19. Lee PH, Oh SH, Bang OY, Joo SY, Joo IS, Huh K: Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease. Neurology 2004; 62: 1291-6.
20. Baron JC: Clinical use of positron emission tomography in cerebrovascular diseases. Neurosurg Clin N Am 1996; 7: 653-64.
21. Rosen BR, Belliveau JW, Vevea JM, Brady TJ: Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-65.
22. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR: High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996; 36: 715-25.
23. Rother J, Guckel F, Neff W, Schwartz A, Hennerici M: Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging. Stroke 1996; 27: 1088-93.
24. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR: Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time? Magn Reson Med 1993; 29: 553-8.
25. Neumann-Haefelin T, Wittsack HJ, Fink GR et al. Diffusion-and perfusion-weighted MRI: Influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. Stroke 2000; 31: 1311-7.
26. Maeda M, Yuh WT, Ueda T et al. Severe occlusive carotid artery disease: hemodynamic assessment by MR perfusion imaging in symptomatic patients [see comments]. Am J Neuroradiol 1999; 20: 43-51.
27. Guckel FJ, Brix G, Schmiedek P et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: Assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 1996; 201: 405-12.
28. Reith W, Heiland S, Erb G, Benner T, Forsting M, Sartor K: Dynamic contrast-enhanced T2 *-weighted MRI in patients with cerebrovascular disease. Neuroradiology 1997; 39: 250-7.
29. Chaves CJ, Silver B, Schlaug G, Dashe J, Caplan LR, Warach S: Diffusion- and perfusion-weighted MRI patterns in borderzone infarcts. Stroke 2000; 31: 1090-6.
30. Detre JA, Zhang W, Roberts DA et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994; 7: 75-82.
31. Detre JA, Alsop DC: Perfusion magnetic resonance imaging with continuous arterial spin labeling: Methods and clinical applications in the central nervous system. Eur J Radiol 1999; 30: 115-24.
32. Warmuth C, Ruping M, Forschler A et al. Dynamic spin labeling angiography in extracranial carotid artery stenosis. Am J Neuroradiol 2005; 26: 1035-43.
33. Sallustio F, Kern R, Günther M et al. Comparison of dynamic arterial spin labeling magnetic resonance angiography and transcranial color coded duplex sonography for the assessment of intracranial collateral flow. Cerebrovasc Dis 2005; 19: 2.
34. Hendrikse J, van Osch MJ, Rutgers DR et al. Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology 2004; 233: 899-904.
35. Günther M, Oshio K, Feinberg DA: Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 2005; 54: 491-8.
36. Griebe M, Kern R, Günther M et al. 3D GRASE ASL is highly sensitive to detect hyperperfusion states in patients with acute stroke. Cerebrovasc Dis 2006; 21: 115.
37. Pasterkamp G, Fitzgerald PF, de Kleijn DP: Atherosclerotic expansive remodeled plaques: A wolf in sheep's clothing. J Vasc Res 2002; 39: 514-23.
38. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
39. Chamorro A: Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004; 17: 1-5.
40. Rugeri L, Bauters A, Trillot N et al. Hemostasis and thrombosis: clinical usefulness of combined use of platelet aggregation test and anti PF4-H. Antibodies elisa test for the diagnosis of heparin induced thrombocytopenia. Hematol 1999; 4: 367-72.
41. Shah PK: Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003; 41: 15S-22S.
42. Meairs S, Hennerici M: Four-dimensional ultrasonographic characterization of plaque surface motion in patients with symptomatic and asymptomatic carotid artery stenosis. Stroke 1999; 30: 1807-13.
43. Meairs S, Timpe L, Beyer J, Hennerici M: Acute aphasia and hemiplegia during karate training. Lancet 2000; 356: 40.
44. The SPARCL Investigators. The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 2006; 21: 1.
45. Barnett HJ, Barnes RW, Clagett GP, Ferguson GG, Robertson JT, Walker PM: Symptomatic carotid artery stenosis: A solvable problem. North American symptomatic carotid endarterectomy trial. Stroke 1992; 23: 1048-53.
46. European Carotid Surgery Trialists' Collaborative Group. MRC European carotid surgery trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-43.
47. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
48. van Heesewijk HP, Vos JA, Louwerse ES et al. New brain lesions at MR imaging after carotid angioplasty and stent placement. Radiology 2002; 224: 361-5.
49. Featherstone RL, Brown MM, Coward LJ: International carotid stenting study: Protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 2004; 18: 69-74.
50. The SPACE Collaborative Group: 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006; 368: 1239-47.
51. The EVA-3S investigators: Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-71.
52. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): A randomised trial. Lancet 2001; 357: 1729-37.